# Investigating Gender and Sex Differences in Immune Responses Through Vaccination of Transgender and Cisgender Persons

> **NCT06832514** · PHASE4 · RECRUITING · sponsor: **University Ghent** · enrollment: 250 (estimated)

## Conditions studied

- Meningococcal Meningitis, Serogroup B
- Transgender Persons
- Sex Differences in Immune Response
- Vaccination

## Interventions

- **BIOLOGICAL:** Serogroup B meningococal vaccine

## Key facts

- **NCT ID:** NCT06832514
- **Lead sponsor:** University Ghent
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-31
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2026-01-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06832514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06832514, "Investigating Gender and Sex Differences in Immune Responses Through Vaccination of Transgender and Cisgender Persons". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06832514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*